The plasminogen activator system: biology and regulation

Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis

Gumbiner, B. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81279-9 · Cited by 3,471

JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor

Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,931

AP-1 function and regulation

Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893

Hox genes in vertebrate development

Krumlauf, R. (1994) · Cell · doi:10.1016/0092-8674(94)90290-9 · Cited by 2,073

Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements

Lee, W., Mitchell, P., & Tjian, R. (1987) · Cell · doi:10.1016/0092-8674(87)90612-x · Cited by 1,983

AU-rich elements: characterization and importance in mRNA degradation

Chen, C.-Y. A., & Shyu, A.-B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89102-1 · Cited by 1,948

Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Hibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886

Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene

Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793

Signal Transduction through MAP Kinase Cascades

(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759

Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to development

Ip, Y. T., & Davis, R. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80143-9 · Cited by 1,547

Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane

Okamoto, T., Schlegel, A., Scherer, P. E., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5419 · Cited by 1,498

Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin

Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442

Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway

Gupta, S., Campbell, D., Dérijard, B., & Davis, R. J. (1995) · Science · doi:10.1126/science.7824938 · Cited by 1,438

mRNA stability in mammalian cells

Ross, J. (1995) · Microbiological Reviews · doi:10.1128/mr.59.3.423-450.1995 · Cited by 1,411

Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.

Hai, T., & Curran, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3720 · Cited by 1,294

MKK3- and MKK6-Regulated Gene Expression Is Mediated by the p38 Mitogen-Activated Protein Kinase Signal Transduction Pathway

Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278

Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin

Carballo, E., Lai, W. S., & Blackshear, P. J. (1998) · Science · doi:10.1126/science.281.5379.1001 · Cited by 1,161

The serpin superfamily of proteinase inhibitors: structure, function, and regulation.

Potempa, J., Korzus, E., & Travis, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33954-6 · Cited by 875

Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs

Fan, X. C., & Steitz, J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3448 · Cited by 866

Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription

Zhang, Y., Feng, X.-H., & Derynck, R. (1998) · Nature · doi:10.1038/29814 · Cited by 809

Homeodomain-DNA recognition

Gehring, W. J., Qian, Y. Q., Billeter, M., Furukubo-Tokunaga, K., Schier, A. F., Resendez-Perez, D., Affolter, M., Otting, G., & Wüthrich, K. (1994) · Cell · doi:10.1016/0092-8674(94)90292-5 · Cited by 794

An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Construct

Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., & Rifkin, D. B. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1042 · Cited by 757

Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade

Mignatti, P., Robbins, E., & Rifkin, D. B. (1986) · Cell · doi:10.1016/0092-8674(86)90613-6 · Cited by 746

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

Eriksson, P., Kallin, B., van 't Hooft, F. M., Båvenholm, P., & Hamsten, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1851 · Cited by 739

Regulation of Integrin Function by the Urokinase Receptor

Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., & Chapman, H. A. (1996) · Science · doi:10.1126/science.273.5281.1551 · Cited by 727

Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions

Eisen, J. A., Sweder, K. S., & Hanawalt, P. C. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2715 · Cited by 717

Protein kinase cascades activated by stress and inflammatory cytokines

Kyriakis, J. M., & Avruch, J. (1996) · BioEssays · doi:10.1002/bies.950180708 · Cited by 709

Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway

Lee, F. S., Hagler, J., Chen, Z. J., & Maniatis, T. (1997) · Cell · doi:10.1016/s0092-8674(00)81842-5 · Cited by 707

Association of the yeast poly(A) tail binding protein with translation initiation factor eIF-4G.

Tarun, S. Z., & Sachs, A. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01108.x · Cited by 688

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677

The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin

Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 674

Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR

Levy, N. S., Chung, S., Furneaux, H., & Levy, A. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6417 · Cited by 663

Degradation of mRNA in eukaryotes

Beelman, C. A., & Parker, R. (1995) · Cell · doi:10.1016/0092-8674(95)90326-7 · Cited by 651

The 3' to 5' degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases of the exosome complex

Anderson, J. S. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1497 · Cited by 650

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

Blasi, F., Vassalli, J., & Danø, K. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.4.801 · Cited by 617

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

Pepper, M. S., Ferrara, N., Orci, L., & Montesano, R. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91276-i · Cited by 615

Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S., & Chapman, H. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31646-6 · Cited by 581

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

Ploug, M., Rønne, E., Behrendt, N., Jensen, A. L., Blasi, F., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52382-6 · Cited by 574

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells

Dawson, S. J., Wiman, B., Hamsten, A., Green, F., Humphries, S., & Henney, A. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82047-6 · Cited by 569

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

Olofsson, B., Korpelainen, E., Pepper, M. S., Mandriota, S. J., Aase, K., Kumar, V., Gunji, Y., Jeltsch, M. M., Shibuya, M., Alitalo, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11709 · Cited by 560

Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1.

Zhang, W., Wagner, B. J., Ehrenman, K., Schaefer, A. W., DeMaria, C. T., Crater, D., DeHaven, K., Long, L., & Brewer, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7652 · Cited by 540

The Nonamer UUAUUUAUU Is the Key AU-Rich Sequence Motif That Mediates mRNA Degradation

Zubiaga, A. M., Belasco, J. G., & Greenberg, M. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2219 · Cited by 538

Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay.

Shyu, A. B., Belasco, J. G., & Greenberg, M. E. (1991) · Genes & Development · doi:10.1101/gad.5.2.221 · Cited by 531

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation

Feng, X.-H., Zhang, Y., Wu, R.-Y., & Derynck, R. (1998) · Genes & Development · doi:10.1101/gad.12.14.2153 · Cited by 525

Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript.

Muhlrad, D., Decker, C. J., & Parker, R. (1994) · Genes & Development · doi:10.1101/gad.8.7.855 · Cited by 512

A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA

Müllner, E. W., Neupert, B., & Kühn, L. C. (1989) · Cell · doi:10.1016/0092-8674(89)90851-9 · Cited by 498

c-Jun Can Recruit JNK to Phosphorylate Dimerization Partners via Specific Docking Interactions

Kallunki, T., Deng, T., Hibi, M., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81999-6 · Cited by 491

Structure and Biological Role of Vitronectin

Preissner, K. T. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.001423 · Cited by 486

Synthesis of fibrinolytic activator and inhibitor by endothelial cells

Loskutoff, D. J., & Edgington, T. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3903 · Cited by 479

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

Chapman, H. A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80126-3 · Cited by 464

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.

Plow, E. F., Freaney, D. E., Plescia, J., & Miles, L. A. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2411 · Cited by 460

Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.

Nykjaer, A., Petersen, C. M., Møller, B., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Munch, M., & Andreasen, P. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42072-8 · Cited by 459

The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation

Angel, P., & Karin, M. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90011-9 · Cited by 450

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

Deng, G., Curriden, S. A., Wang, S., Rosenberg, S., & Loskutoff, D. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.6.1563 · Cited by 448

An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus

Tsirka, S. E., Rogove, A. D., Bugge, T. H., Degen, J. L., & Strickland, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00543.1997 · Cited by 430

Premature translational termination triggers mRNA decapping

Muhlrad, D., & Parker, R. (1994) · Nature · doi:10.1038/370578a0 · Cited by 415

Vitronectin and its receptors

Felding-Habermann, B., & Cheresh, D. A. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90036-p · Cited by 413

Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.

Emeis, J. J., & Kooistra, T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1260 · Cited by 410

Plasminogen activator inhibitors: hormonally regulated serpins

Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A., & Stacey, S. N. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90164-4 · Cited by 398

Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin

Chen, Y.-R., & Tan, T.-H. (1998) · Oncogene · doi:10.1038/sj.onc.1201941 · Cited by 392

Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy

Schmitt, M., Harbeck, N., Thomssen, C., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657541 · Cited by 386

PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

Juhan-Vague, I., & Alessi, M. C. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657607 · Cited by 384

Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element.

Sassone-Corsi, P., Visvader, J., Ferland, L., Mellon, P. L., & Verma, I. M. (1988) · Genes & Development · doi:10.1101/gad.2.12a.1529 · Cited by 380

Amiloride selectively inhibits the urokinase‐type plasminogen activator

Vassalli, J.-D., & Belin, D. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80039-x · Cited by 380

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

Ny, T., Sawdey, M., Lawrence, D., Millan, J. L., & Loskutoff, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6776 · Cited by 379

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

Cubellis, M. V., Wun, T. C., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08213.x · Cited by 371

Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation

Craig, A. W. B., Haghighat, A., Yu, A. T. K., & Sonenberg, N. (1998) · Nature · doi:10.1038/33198 · Cited by 367

Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation

Johnsen, M., Lund, L. R., Rømer, J., Almholt, K., & Danø, K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80044-6 · Cited by 356

A Mouse Cytoplasmic Exoribonuclease (mXRN1p) with Preference for G4 Tetraplex Substrates

Bashkirov, V. I., Scherthan, H., Solinger, J. A., Buerstedde, J.-M., & Heyer, W.-D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.4.761 · Cited by 348

DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1.

Su, W., Jackson, S., Tjian, R., & Echols, H. (1991) · Genes & Development · doi:10.1101/gad.5.5.820 · Cited by 347

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.

Ginsburg, D., Zeheb, R., Yang, A. Y., Rafferty, U. M., Andreasen, P. A., Nielsen, L., Dano, K., Lebo, R. V., & Gelehrter, T. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112761 · Cited by 346

Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.

Bohuslav, J., Horejsí, V, Hansmann, C., Stöckl, J., Weidle, U. H., Majdic, O., Bartke, I., Knapp, W., & Stockinger, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1381 · Cited by 345

Autoregulated instability of β-tubulin mRNAs by recognition of the nascent amino terminus of βtubulin

Yen, T. J., Machlin, P. S., & Cleveland, D. W. (1988) · Nature · doi:10.1038/334580a0 · Cited by 341

Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA.

Casey, J. L., Koeller, D. M., Ramin, V. C., Klausner, R. D., & Harford, J. B. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08544.x · Cited by 338

AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A).

Lagnado, C. A., Brown, C. Y., & Goodall, G. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7984 · Cited by 338

Biological and clinical aspects of plasminogen activator inhibitor type 2

Kruithof, E., Baker, M., & Bunn, C. (1995) · Blood · doi:10.1182/blood.v86.11.4007.bloodjournal86114007 · Cited by 338

Ras-Mediated Phosphorylation of a Conserved Threonine Residue Enhances the Transactivation Activities of c-Ets1 and c-Ets2

Yang, B.-S., Hauser, C. A., Henkel, G., Colman, M. S., Beveren, C. V., Stacey, K. J., Hume, D. A., Maki, R. A., & Ostrowski, M. C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.2.538 · Cited by 333

Heterodimer formation between CREB and JUN proteins.

Benbrook, D. M., & Jones, N. (1990) · PubMed · Cited by 331

An essential component of the decapping enzyme required for normal rates of mRNA turnover

Beelman, C. A., Stevens, A., Caponigro, G., LaGrandeur, T. E., Hatfield, L., Fortner, D. M., & Parker, R. (1996) · Nature · doi:10.1038/382642a0 · Cited by 327

Regulation of the ERK Subgroup of MAP Kinase Cascades Through G Protein-Coupled Receptors

Sugden, P. H., & Clerk, A. (1997) · Cellular Signalling · doi:10.1016/s0898-6568(96)00191-x · Cited by 326

Stress-activated Protein Kinases: Activation, Regulation and Function

Paul, A., Wilson, S., Belham, C. M., Robinson, C. J. M., Scott, P. H., Gould, G. W., & Plevin, R. (1997) · Cellular Signalling · doi:10.1016/s0898-6568(97)00042-9 · Cited by 321

The ETS-domain transcription factor family

Sharrocks, A. D., Brown, A. L., Ling, Y., & Yates, P. R. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00086-1 · Cited by 318

Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.

Keeton, M. R., Curriden, S. A., van Zonneveld, A. J., & Loskutoff, D. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54461-6 · Cited by 316

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

Nykjar, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2610 · Cited by 309

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.

Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F., & Fazioli, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00502.x · Cited by 299

The riddle of MAP kinase signaling specificity

Madhani, H. D., & Fink, G. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01425-5 · Cited by 293

An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA.

Bohjanen, P. R., Petryniak, B., June, C. H., Thompson, C. B., & Lindsten, T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3288 · Cited by 288

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

Waltz, D. A., Natkin, L. W., Fujita, R. M., Wei, Y., & Chapman, H. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119521 · Cited by 288

The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors.

Wisdom, R., & Lee, W. (1991) · Genes & Development · doi:10.1101/gad.5.2.232 · Cited by 285

Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene

Hua, X., Liu, X., Ansari, D. O., & Lodish, H. F. (1998) · Genes & Development · doi:10.1101/gad.12.19.3084 · Cited by 283

Multiple functions for the poly(A)-binding protein in mRNA decapping and deadenylation in yeast.

Caponigro, G., & Parker, R. (1995) · Genes & Development · doi:10.1101/gad.9.19.2421 · Cited by 279

Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells

Iwasaka, C., Tanaka, K., Abe, M., & Sato, Y. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199612)169:3<522::aid-jcp12>3.0.co;2-7 · Cited by 278

Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.

Ellis, V, Wun, T. C., Behrendt, N., Rønne, E., & Danø, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38757-5 · Cited by 266

The Adipocyte and Hemostatic Balance in Obesity: Studies of PAI-1

Loskutoff, D. J., & Samad, F. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.1.1 · Cited by 264

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.

Busso, N., Masur, S. K., Lazega, D., Waxman, S., & Ossowski, L. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.1.259 · Cited by 263

Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase.

Laiho, M., Saksela, O., & Keski-Oja, J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45403-8 · Cited by 257

DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement.

Mastrangelo, I. A., Courey, A. J., Wall, J. S., Jackson, S. P., & Hough, P. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5670 · Cited by 257

The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation

Wulczyn, F. G., Krappmann, D., & Scheidereit, C. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050078 · Cited by 256

Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.

Høyer-Hansen, G., Rønne, E., Solberg, H., Behrendt, N., Ploug, M., Lund, L. R., Ellis, V, & Danø, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37176-5 · Cited by 252

Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.

Lund, L. R., Riccio, A., Andreasen, P. A., Nielsen, L. S., Kristensen, P., Laiho, M., Saksela, O., Blasi, F., & Danø, K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02365.x · Cited by 247

Structure—function relationships in the receptor for urokinase‐type plasminogen activator Comparison to other members of the Ly‐6 family and snake venom α‐neurotoxins

Ploug, M., & Ellis, V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00674-1 · Cited by 246

Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell Migration

Yebra, M., Parry, G. C. N., Strömblad, S., Mackman, N., Rosenberg, S., Mueller, B. M., & Cheresh, D. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29393 · Cited by 242

Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.

Keski-Oja, J., Raghow, R., Sawdey, M., Loskutoff, D. J., Postlethwaite, A. E., Kang, A. H., & Moses, H. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69042-8 · Cited by 241

Regulated polyadenylation controls mRNA translation during meiotic maturation of mouse oocytes.

Vassalli, J. D., Huarte, J., Belin, D., Gubler, P., Vassalli, A., O'Connell, M. L., Parton, L. A., Rickles, R. J., & Strickland, S. (1989) · Genes & Development · doi:10.1101/gad.3.12b.2163 · Cited by 240

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity

Fazioli, F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7279 · Cited by 238

Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver

Mendelson, K. G., Contois, L.-R., Tevosian, S. G., Davis, R. J., & Paulson, K. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12908 · Cited by 234

Transient translational silencing by reversible mRNA deadenylation

Huarte, J., Stutz, A., O'Connell, M. L., Gubler, P., Belin, D., Darrow, A. L., Strickland, S., & Vassalli, J.-D. (1992) · Cell · doi:10.1016/0092-8674(92)90620-r · Cited by 234

Plasminogen Activator Inhibitor-1 Represses Integrin- and Vitronectin-Mediated Cell Migration Independently of Its Function as an Inhibitor of Plasminogen Activation

Kjøller, L., Kanse, S. M., Kirkegaard, T., Rodenburg, K. W., Rønne, E., Goodman, S. L., Preissner, K. T., Ossowski, L., & Andreasen, P. A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3540 · Cited by 233

FIBRINOGEN AND FIBRIN-PROTEINS WITH COMPLEX ROLES IN HEMOSTASIS AND THROMBOSIS

Blombäck, B. (1996) · Thrombosis Research · doi:10.1016/0049-3848(96)00111-9 · Cited by 233

Embryonic Lethal Abnormal Visual RNA-Binding Proteins Involved in Growth, Differentiation, and Posttranscriptional Gene Expression

Antic, D., & Keene, J. D. (1997) · The American Journal of Human Genetics · doi:10.1086/514866 · Cited by 231

Poly(A) Tail Shortening by a Mammalian Poly(A)-specific 3′-Exoribonuclease

Körner, C. G., & Wahle, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10448 · Cited by 230

Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor α-induced Apoptosis

Dickinson, J. L., Bates, E. J., Ferrante, A., & Antalis, T. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27894 · Cited by 228

The human tissue plasminogen activator gene.

Degen, S. J., Rajput, B., & Reich, E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62711-0 · Cited by 224

Dephosphorylation of Sp1 by Protein Phosphatase 1 Is Involved in the Glucose-mediated Activation of the Acetyl-CoA Carboxylase Gene

Daniel, S., Zhang, S., DePaoli-Roach, A. A., & Kim, K.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14692 · Cited by 224

Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.

Xue, W., Mizukami, I. F., Todd, R. F., & Petty, H. R. (1997) · PubMed · Cited by 221

Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation.

Lamph, W. W., Dwarki, V. J., Ofir, R., Montminy, M., & Verma, I. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4320 · Cited by 219

Surface receptors for urokinase plasminogen activator

Blasi, F. (1988) · Fibrinolysis · doi:10.1016/0268-9499(88)90370-0 · Cited by 218

Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells

Chen, Y.-Q., Su, M., Walia, R. R., Hao, Q., Covington, J. W., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8225 · Cited by 217

The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor

Watabe, T., Yoshida, K., Shindoh, M., Kaya, M., Fujikawa, K., Sato, H., Seiki, M., Ishii, S., & Fujinaga, K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980703)77:1<128::aid-ijc20>3.0.co;2-9 · Cited by 217

Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.

van Zonneveld, A. J., Curriden, S. A., & Loskutoff, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5525 · Cited by 215

Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy.

Waltz, D. A., & Chapman, H. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36688-7 · Cited by 210

Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences.

Hamilton, B. J., Nagy, E., Malter, J. S., Arrick, B. A., & Rigby, W. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52955-0 · Cited by 209

Translation initiation requires the PAB-dependent poly(A) ribonuclease in yeast

Sachs, A. B., & Deardorff, J. A. (1992) · Cell · doi:10.1016/0092-8674(92)90246-9 · Cited by 209

Messenger RNA deadenylylation precedes decapping in mammalian cells

Couttet, P., Fromont-Racine, M., Steel, D., Pictet, R., & Grange, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5628 · Cited by 209

The human urokinase-plasminogen activator gene and its promoter

Riccio, A., Grimaldi, G., Verde, P., Sebastio, G., Boast, S., & Blasi, F. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.8.2759 · Cited by 207

Autoregulation of tubulin expression is achieved through specific degradation of polysomal tubulin mRNAs

PACHTER, J. (1987) · Cell · doi:10.1016/0092-8674(87)90155-3 · Cited by 206

Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility

Nguyen, D. H. D., Hussaini, I. M., & Gonias, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8502 · Cited by 205

Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA.

Huarte, J., Belin, D., Vassalli, A., Strickland, S., & Vassalli, J. D. (1987) · Genes & Development · doi:10.1101/gad.1.10.1201 · Cited by 204

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.

Juhan-Vague, I., Alessi, M. C., Joly, P., Thirion, X., Vague, P., Declerck, P. J., Serradimigni, A., & Collen, D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.3.362 · Cited by 201

The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.

Stahl, A., & Mueller, B. M. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.2.335 · Cited by 198

Purification of a Protein from Bovine Plasma That Binds to Type 1 Plasminogen Activator Inhibitor and Prevents Its Interaction with Extracellular Matrix

Mimuro, J., & Loskutoff, D. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85032-9 · Cited by 195

alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.

Conese, M., Nykjaer, A., Petersen, C. M., Cremona, O., Pardi, R., Andreasen, P. A., Gliemann, J., Christensen, E. I., & Blasi, F. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.6.1609 · Cited by 191

Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.

Cubellis, M. V., Nolli, M. L., Cassani, G., & Blasi, F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66635-9 · Cited by 187

Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2.

Kumar, S., & Baglioni, C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54804-3 · Cited by 186

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.

Olson, D., Pöllänen, J., Høyer-Hansen, G., Rønne, E., Sakaguchi, K., Wun, T. C., Appella, E., Danø, K., & Blasi, F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50398-2 · Cited by 184

Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

Gyetko, M. R., Chen, G. H., McDonald, R. A., Goodman, R., Huffnagle, G. B., Wilkinson, C. C., Fuller, J. A., & Toews, G. B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118611 · Cited by 183

Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.

Cubellis, M. V., Andreasen, P., Ragno, P., Mayer, M., Danø, K., & Blasi, F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4828 · Cited by 180

The Jak/Stat Pathway and Urokinase Receptor Signaling in Human Aortic Vascular Smooth Muscle Cells

Dumler, I., Weis, A., Mayboroda, O. A., Maasch, C., Jerke, U., Haller, H., & Gulba, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.315 · Cited by 176

Urokinase Receptor Is Associated with the Components of the JAK1/STAT1 Signaling Pathway and Leads to Activation of This Pathway upon Receptor Clustering in the Human Kidney Epithelial Tumor Cell Line TCL-598

Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P. C., & Binder, B. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28563 · Cited by 175

Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences.

Bosma, P. J., van den Berg, E. A., Kooistra, T., Siemieniak, D. R., & Slightom, J. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)76517-x · Cited by 171

A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.

Hansen, S. K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P. A., & Blasi, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05043.x · Cited by 168

Biochemical and biological aspects of the plasminogen activation system

Mayer, M. (1990) · Clinical Biochemistry · doi:10.1016/0009-9120(90)90601-p · Cited by 164

Rapid Phosphorylation of Ets-2 Accompanies Mitogen-Activated Protein Kinase Activation and the Induction of Heparin-Binding Epidermal Growth Factor Gene Expression by Oncogenic Raf-1

McCarthy, S. A., Chen, D., Yang, B.-S., Garcia Ramirez, J. J., Cherwinski, H., Chen, X.-R., Klagsbrun, M., Hauser, C. A., Ostrowski, M. C., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2401 · Cited by 163

Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.

Schneider, D. J., & Sobel, B. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9959 · Cited by 161

Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.

Medcalf, R. L., Van den Berg, E., & Schleuning, W. D. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.971 · Cited by 160

The Urokinase-type Plasminogen Activator Receptor Mediates Tyrosine Phosphorylation of Focal Adhesion Proteins and Activation of Mitogen-activated Protein Kinase in Cultured Endothelial Cells

Tang, H., Kerins, D. M., Hao, Q., Inagami, T., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18268 · Cited by 159

Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme

LaGrandeur, T. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1487 · Cited by 159

Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells.

Westerhausen, D., Hopkins, W. E., & Billadello, J. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35287-0 · Cited by 155

AU RNA-binding factors differ in their binding specificities and affinities.

Bohjanen, P. R., Petryniak, B., June, C. H., Thompson, C. B., & Lindsten, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42696-8 · Cited by 154

Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

Bugge, T. H., Lund, L. R., Kombrinck, K. K., Nielsen, B. S., Holmbäck, K., Drew, A. F., Flick, M. J., Witte, D. P., Danø, K., & Degen, J. L. (1998) · Oncogene · doi:10.1038/sj.onc.1201869 · Cited by 153

A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy

Xu, N., Loflin, P. T., Chen, C.-Y. A., & Shyu, A. B. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.2.558 · Cited by 150

Regulation of the mRNA-binding Protein AUF1 by Activation of the β -Adrenergic Receptor Signal Transduction Pathway

Pende, A., Tremmel, K. D., DeMaria, C. T., Blaxall, B. C., Minobe, W. A., Sherman, J. A., Bisognano, J. D., Bristow, M. R., Brewer, G., & Port, J. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8493 · Cited by 149

Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells

Nagamine, Y., Sudol, M., & Reich, E. (1983) · Cell · doi:10.1016/0092-8674(83)90301-x · Cited by 147

Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53

Kunz, C., Pebler, S., Otte, J., & von der Ahe, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3710 · Cited by 145

Smad4/DPC4 and Smad3 Mediate Transforming Growth Factor-β (TGF-β) Signaling through Direct Binding to a Novel TGF-β-responsive Element in the Human Plasminogen Activator Inhibitor-1 Promoter

Song, C.-Z., Siok, T. E., & GELEHRTER, T. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29287 · Cited by 144

The Receptor for Urokinase-type Plasminogen Activator is Expressed by Keratinocytes at the Leading Edge During Re-Epithelialization of Mouse Skin Wounds

Rømer, J., Lund, L. R., Eriksen, J., Pyke, C., Kristensen, P., & Danø, K. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12373187 · Cited by 143

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma.

Pyke, C., Kristensen, P. K., Ralfkiaer, E. M., Eriksen, J., & Danø, K. (1991) · PubMed · Cited by 143

Thrombogenic and Fibrinolytic Factors and Cardiovascular Risk in Non-insulin-dependent Diabetes Mellitus

Juhan-Vague, I., Alessi, M., & Vague, P. (1996) · Annals of Medicine · doi:10.3109/07853899608999095 · Cited by 142

Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester

Rørth, P., Nerlov, C., Blasi, F., & Johnsen, M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5009 · Cited by 141

Control of gene expression by proteolysis

Pahl, H. L., & Baeuerle, P. A. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80007-x · Cited by 141

Hydrolysis of Phosphatidylcholine Couples Ras to Activation of Raf Protein Kinase During Mitogenic Signal Transduction

Cai, H., Erhardt, P., Troppmair, J., Díaz-Meco, M. T., Sithanandam, G., Rapp, U. R., Moscat, J., & Cooper, G. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7645 · Cited by 138

The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1.

Prendergast, G. C., Diamond, L. E., Dahl, D., & Cole, M. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1265 · Cited by 136

The role of E2F in the mammalian cell cycle

Farnham, P., Slansky, J. E., & Kollamar, R. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90001-s · Cited by 134

A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP.

Medcalf, R. L., Rüegg, M., & Schleuning, W. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77347-x · Cited by 133

Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.

Nordt, T., Klassen, K. J., Schneider, D. J., & Sobel, B. E. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1822 · Cited by 130

Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis

Xiao, Q., Danton, M. J. S., Witte, D. P., Kowala, M. C., Valentine, M. T., Bugge, T. H., & Degen, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10335 · Cited by 130

Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis

Carmeliet, P., Moons, L., & Collen, D. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00108-4 · Cited by 129

Regulation of Urokinase-Type Plasminogen Activator Gene Transcription by Macrophage Colony-Stimulating Factor

Stacey, K. J., Fowles, L., Colman, M. S., Ostrowski, M. C., & Hume, D. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3430 · Cited by 128

A regulatory element that mediates co‐operation between a PEA3‐AP‐1 element and an AP‐1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells.

Nerlov, C., Cesare, D. D., Pergola, F., Caracciolo, A., Blasi, F., Johnsen, M., & Verde, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05559.x · Cited by 126

Obesity and cardiovascular disease

Sowers, J. R. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1821 · Cited by 126

Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer.

Hollas, W., Blasi, F., & Boyd, D. D. (1991) · PubMed · Cited by 125

Abdominal obesity and its metabolic complications

Lamarche, B. (1998) · Coronary Artery Disease · doi:10.1097/00019501-199809080-00002 · Cited by 122

Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region.

Fisher, R. A., Waller, E. K., Grossi, G., Thompson, D., Tizard, R., & Schleuning, W. D. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39169-x · Cited by 121

EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.

Liu, C., Calogero, A., Ragona, G., et al. (1996) · PubMed · Cited by 121

Plasminogen activation in healing human wounds.

Schäfer, B., Maier, K., Eickhoff, U., Todd, R. F., & Kramer, M. D. (1994) · PubMed Central · Cited by 120

Transforming Growth Factor βl-Responsive Element: Closely Associated Binding Sites for USF and CCAAT-Binding Transcription Factor-Nuclear Factor I in the Type 1 Plasminogen Activator Inhibitor Gene

Riccio, A., Pedone, P. V., Lund, L. R., Olesen, T., Olsen, H. S., & Andreasen, P. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1846 · Cited by 118

Urokinase‐receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.

Lund, L. R., Rømer, J., Rønne, E., Ellis, V., Blasi, F., & Danø, K. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04904.x · Cited by 115

cDNA and gene nucleotide sequence of porcine plasminogen activator

Nagamine, Y., Pearson, D., Altus, M. S., et al. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.24.9525 · Cited by 115

Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice

Bugge, T. H., Kombrinck, K. W., Xiao, Q., Holmbäck, K., Daugherty, C. C., Witte, D. P., & Degen, J. L. (1997) · Blood · doi:10.1182/blood.v90.11.4522 · Cited by 114

Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.

Heiss, M. M., Babic, R., Allgayer, H., Gruetzner, K. U., Jauch, K. W., Loehrs, U., & Schildberg, F. W. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.8.2084 · Cited by 112

Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading

Planus, E., Barlovatz‐Meimon, G., Rogers, R. A., Bonavaud, S. M., Ingber, D. E., & Wang, N. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.9.1091 · Cited by 111

An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene

Verde, P., Boast, S., Franzè, A., Robbiati, F., & Blasi, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.22.10699 · Cited by 108

Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA

Nair, A. P. K., Hahn, S., Banholzer, R., Hirsch, H. H., & Moroni, C. (1994) · Nature · doi:10.1038/369239a0 · Cited by 108

Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns

Loskutoff, D. J., Linders, M. T. J., Keijer, J., Veerman, H., van Heerikhuizen, H., & Pannekoek, H. (1987) · Biochemistry · doi:10.1021/bi00387a004 · Cited by 108

Masking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytesPreprint

Stutz, A., Conne, B., Huarte, J., Gubler, P., Völkel, V., Flandin, P., & Vassalli, J. (1998) · Genes & Development · doi:10.1101/gad.12.16.2535 · Cited by 108

Ligneous Conjunctivitis in Plasminogen-Deficient Mice

Drew, A. F., Kaufman, A. H., Kombrinck, K. W., et al. (1998) · Blood · doi:10.1182/blood.v91.5.1616 · Cited by 107

Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells.

Santell, L., & Levin, E. G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37462-3 · Cited by 107

Plasminogen Activator System: Implications for Mammary Cell Growth and Involution

Politis, I. (1996) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(96)76463-9 · Cited by 106

Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response.

Descheemaeker, K. A., Wyns, S., Nelles, L., Auwerx, J. H., Ny, T., & Collen, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42149-7 · Cited by 104

Downstream targets of urokinase‐type plasminogen‐activator‐mediated signal transduction

Konakova, M., Hucho, F., & Schleuning, W.-D. D. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530421.x · Cited by 104

Posttranscriptional Regulation of Urokinase Receptor mRNA: Identification of a Novel Urokinase Receptor mRNA Binding Protein in Human Mesothelioma Cells

Shetty, S., Kumar, A., & Idell, S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1075 · Cited by 104

Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1.

Fattal, P. G., Schneider, D. J., Sobel, B. E., & Billadello, J. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42289-2 · Cited by 103

β2(CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors

Todd, R. F., & Petty, H. R. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90003-2 · Cited by 103

Structure of the Gene for Human Plasminogen Activator Inhibitor-2

Ye, R. D., Ahern, S., Beau, M. M. L., Lebo, R. V., & Sadler, J. E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83572-4 · Cited by 97

Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.

Myöhänen, H., Stephens, R. W., Hedman, K., Tapiovaara, H., Rønne, E., Høyer‐Hansen, G., Danø, K., & Vaheri, A. I. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.9.8394852 · Cited by 97

A closer look at E2F

Nevins, J. R. (1992) · Nature · doi:10.1038/358375a0 · Cited by 96

Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides.

Chen, Z.-Q., Fisher, R. J., Riggs, C. W., Rhim, J. S., & Lautenberger, J. A. (1997) · PubMed · Cited by 95

Interleukin 1 (IL1) and tumour necrosis factor (TNF) signal transduction

Saklatvala, J., Davis, W., Guesdon, F., & Marshall, C. J. (1996) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1996.0011 · Cited by 92

Differentiation-Responsive Elements in the 5′ Region of the Mouse Tissue Plasminogen Activator Gene Confer Two-Stage Regulation by Retinoic Acid and Cyclic AMP in Teratocarcinoma Cells

Rickles, R. J., Darrow, A. L., & Strickland, S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1691 · Cited by 90

The extracellular matrix in breast cancer

Insua-Rodríguez, J., & Oskarsson, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.017 · Cited by 470

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications

Mahmood, N., Mihalcioiu, C., & Rabbani, S. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00024 · Cited by 478

Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes

Fata, J. E., Werb, Z., & Bissell, M. J. (2003) · Breast Cancer Research · doi:10.1186/bcr634 · Cited by 383

MATHEMATICAL MODELLING OF CANCER CELL INVASION OF TISSUE: THE ROLE OF THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM

CHAPLAIN, M. A. J., & LOLAS, G. (2005) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202505000947 · Cited by 323

The urokinase plasminogen activator system: a target for anti-cancer therapy

Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312